2025-04-08 17:40:09
Latest Post
Godrej Properties delivers its highest ever quarterly and full year bookings
Poonawalla Fincorp Launches Shopkeeper Loan Business
Revolt Motors Expands to 200 Dealerships, Targets 400 by FY26
Sobha Ltd - Real Estate Operational Update - Q4 FY 2024-25
Lemon Tree Hotels signs a new property in DarjeelingStock Report
Dr. Reddy's Laboratories Ltd Q1FY21 consolidated net profit lower at Rs. 579.3 crore
Posted On : 2020-07-29 13:49:25( TIMEZONE : IST )
DR.REDDY'S LABORATORIES LTD. has reported financial results for the period ended June 30, 2020.
Financial Results (Q1 FY 2020-21) - QoQ Comparison
The company has reported total income of Rs.4417.5 crores during the period ended June 30, 2020 as compared to Rs.4431.8 crores during the period ended March 31, 2020.
The company has posted net profit / (loss) of Rs.579.3 crores for the period ended June 30, 2020 as against net profit / (loss) of Rs.764.2 crores for the period ended March 31, 2020.
The company has reported EPS of Rs.34.86 for the period ended June 30, 2020 as compared to Rs.46.01 for the period ended March 31, 2020.
| Financials | Q1 FY2020-21 | Q4 FY19-20 | % Change |
| Total Income | ₹ 4417.5 crs | ₹ 4431.8 crs |  -0.32% |
| Net Profit | ₹ 579.3 crs | ₹ 764.2 crs | -24.2% |
| EPS | ₹ 34.86 | ₹ 46.01 | -24.23% |
Financial Results (Q1 FY 2020-21) - YoY Comparison
The company has reported total income of Rs.4417.5 crores during the period ended June 30, 2020 as compared to Rs.3843.5 crores during the period ended June 30, 2019.
The company has posted net profit / (loss) of Rs.579.3 crores for the period ended June 30, 2020 as against net profit / (loss) of Rs.662.8 crores for the period ended June 30, 2019.
The company has reported EPS of Rs.34.86 for the period ended June 30, 2020 as compared to Rs.39.91 for the period ended June 30, 2019.
| Financials | Q1 FY2020-21 | Q1 FY2019-20 | % Change |
| Total Income | ₹ 4417.5 crs | ₹ 3843.5 crs |  14.93% |
| Net Profit | ₹ 579.3 crs | ₹ 662.8 crs | -12.6% |
| EPS | ₹ 34.86 | ₹ 39.91 | -12.65% |
Commenting on the results, Co-chairman & MD, G V Prasad said "the current quarter's financial performance has been strong across all parameter.<;. lam glad that we have been able to serve our patients well and ensured continuity of business operations despite the challenging times. We have started integration of the acquired business from Wockhardt and executed two important licencing arrangements for treatment options for COVID-19. Currently, we are working towards bringing both these drugs to multiple markets".
Shares of DR.REDDY'S LABORATORIES LTD. was last trading in BSE at Rs.4050.45 as compared to the previous close of Rs. 4015.25. The total number of shares traded during the day was 25864 in over 2198 trades.
The stock hit an intraday high of Rs. 4092.95 and intraday low of 4019.65. The net turnover during the day was Rs. 105118750.
